Serum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injury.

MLA

Garantziotis S, et al. “Serum Inter-Alpha-Trypsin Inhibitor and Matrix Hyaluronan Promote Angiogenesis in Fibrotic Lung Injury.” American Journal of Respiratory & Critical Care Medicine, vol. 178, no. 9, Nov. 2008, pp. 939–47. EBSCOhost, https://doi.org/10.1164/rccm.200803-386OC.

APA

Garantziotis S, Zudaire E, Trempus CS, Hollingsworth JW, Jiang D, Lancaster LH, Richardson E, Zhuo L, Cuttitta F, Brown KK, Noble PW, Kimata K, Schwartz DA, Garantziotis, S., Zudaire, E., Trempus, C. S., Hollingsworth, J. W., Jiang, D., Lancaster, L. H., & Richardson, E. (2008). Serum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injury. American Journal of Respiratory & Critical Care Medicine, 178(9), 939–947. https://doi.org/10.1164/rccm.200803-386OC

Chicago

Garantziotis S, Zudaire E, Trempus CS, Hollingsworth JW, Jiang D, Lancaster LH, Richardson E, et al. 2008. “Serum Inter-Alpha-Trypsin Inhibitor and Matrix Hyaluronan Promote Angiogenesis in Fibrotic Lung Injury.” American Journal of Respiratory & Critical Care Medicine 178 (9): 939–47. doi:10.1164/rccm.200803-386OC.